Zanganeh Mahkam 13D and 13G filings for Summit Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-13 4:51 pm Purchase | 2023-03-08 | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 36,882,393 5.270% | 31,399,111 (+572.63%) | Filing |
| 2020-11-25 4:11 pm Purchase | 2020-11-22 | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,483,282 6.580% | 3,323 (+0.06%) | Filing |
| 2020-11-10 4:20 pm Purchase | 2020-11-06 | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,479,959 6.580% | 149,701 (+2.81%) | Filing |
| 2020-09-28 4:40 pm Purchase | 2020-09-18 | 13D | Summit Therapeutics Inc. SMMT | Zanganeh Mahkam | 5,330,258 7.800% | 5,330,258 (New Position) | Filing |